HomeAbout

TL;DR CNBC


Alphabet's new CFO was in the middle of the GLP-1 boom. Now she's onto generative AI - TL;DR CNBC

Alphabet's new CFO was in the middle of the GLP-1 boom. Now she's onto generative AI

Publishing timestamp: 2024-06-06 12:18:40


Summary

Anat Ashkenazi, the incoming CFO of Alphabet, has experience running books at Eli Lilly during a period of historic growth. Eli Lilly has become the most valuable drugmaker in the world due to the success of weight loss drugs. Ashkenazi will be entering Alphabet at a time of big changes, with the company focusing on investments in generative artificial intelligence.


Sentiment: NEUTRAL

Tickers: LLYGOOGLMS

Keywords: pharmaceuticalsgooglebreaking news: technologysergey brininternetsundar pichaibusiness newstechnologymorgan stanleyalphabet inceli lilly and co

Source: https://www.cnbc.com/2024/06/06/alphabet-cfo-anat-ashkenazi-jumps-from-glp-1-boom-to-generative-ai.html


Developed by Leo Phan